Evidence map›Paper›PMID 33626358›Full record

ArticleCell reports2021

Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies.

Laura K Jennings, Julia E Dreifus, Courtney Reichhardt, Kelly M Storek, Patrick R Secor, Daniel J Wozniak, Katherine B Hisert, Matthew R Parsek

Abstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed.

  1. TheVirulence · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Calcium regulation ofApplied and environmental microbiology · 2026
    Article
  7. The effect ofiScience · 2026
    Article
  8. Article
  9. Role of cell-associated and secretion-independent virulence factors of Pseudomonas aeruginosa in microbial keratitis and anti-virulence therapeutic strategies.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  10. Review
  11. Article
  12. Article
  13. Extracellular matrix chemistry tunes bacterial biofilm metabolism and optimizes fitness.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  14. Article
  15. Biophysical Constraints Dictate the Stability of Social Traits inbioRxiv : the preprint server for biology · 2026
    Article
  16. Article
  17. Mechanisms ofMedicina (Kaunas, Lithuania) · 2026
    Review
  18. A broad-host-range inhalable phage cocktail for treatment of multidrug-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  19. BioMed research international · 2026
    Review
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura K JenningsDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA.
Julia E DreifusDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA.
Courtney ReichhardtDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA.
Kelly M StorekDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA.
Patrick R SecorDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA.
Daniel J WozniakDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA; Department of Microbiology, The Ohio State University, Columbus, OH 43210, USA; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210, USA.
Katherine B HisertDepartment of Medicine, University of Washington, Seattle, WA 98195, USA.
Matthew R ParsekDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA. Electronic address: parsem@u.washington.edu.

Funding

Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP20GM103546 · NIGMS · UNIVERSITY OF MONTANA · PI BOWLER, BRUCE E · 2012 to 2021
$19.2M
The pel exopolysaccharide gene cluster of Pseudomonas aeruginosaR01AI077628 · NIAID · UNIVERSITY OF WASHINGTON · PI MATTHEW R. PARSEK, Daniel J Wozniak · 2009 to 2026
$7.1M
Immunization against filamentous bacteriophages to prevent bacterial infectionR01AI138981 · NIAID · UNIVERSITY OF MONTANA · PI EVANS, JAY T. · 2018 to 2022
$5.4M
The biofilm matrix of P. aeruginosaR01AI143916 · NIAID · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL, PARSEK, MATTHEW R. · 2019 to 2023
$2.9M
Revisiting alginate paradigmsR01AI134895 · NIAID · OHIO STATE UNIVERSITY · PI WOZNIAK, DANIEL J · 2018 to 2022
$2.5M
Modulating macrophage-mediated Inflammation in cystic fibrosisK08HL136786 · NHLBI · UNIVERSITY OF WASHINGTON · PI HISERT, KATHERINE B · 2018 to 2022
$797k
Functionality of CdrA and its processed forms within Pseudomonas aeruginosa biofilmsR00GM134121 · NIGMS · WASHINGTON UNIVERSITY · PI REICHHARDT, COURTNEY · 2021 to 2023
$747k
Functionality of CdrA and its processed forms within Pseudomonas aeruginosa biofilmsK99GM134121 · NIGMS · UNIVERSITY OF WASHINGTON · PI REICHHARDT, COURTNEY · 2019 to 2020
$178k
NHLBI NIH HHS K08 HL136786NIAID NIH HHS R01 AI077628NIAID NIH HHS R01 AI134895NIAID NIH HHS R01 AI138981NIAID NIH HHS R01 AI143916NIGMS NIH HHS K99 GM134121NIGMS NIH HHS P20 GM103546NIGMS NIH HHS R00 GM134121
6 · The paper itself

Abstract

In cystic fibrosis (CF) airways, Pseudomonas aeruginosa forms cellular aggregates called biofilms that are thought to contribute to chronic infection. To form aggregates, P. aeruginosa can use different mechanisms, each with its own pathogenic implications. However, how they form in vivo is controversial and unclear. One mechanism involves a bacterially produced extracellular matrix that holds the aggregates together. Pel and Psl exopolysaccharides are structural and protective components of this matrix. We develop an immunohistochemical method to visualize Pel and Psl in CF sputum. We demonstrate that both exopolysaccharides are expressed in the CF airways and that the morphology of aggregates is consistent with an exopolysaccharide-dependent aggregation mechanism. We reason that the cationic exopolysaccharide Pel may interact with some of the abundant anionic host polymers in sputum. We show that Pel binds extracellular DNA (eDNA) and that this interaction likely impacts current therapies by increasing antimicrobial tolerance and protecting eDNA from digestion.

Indexed as

Anti-Bacterial AgentsBiofilmsCystic FibrosisDNA, BacterialDrug Resistance, BacterialExpectorantsHumansLungPolysaccharides, BacterialPseudomonas aeruginosaPseudomonas InfectionsRespiratory Tract InfectionsSputumAnti-Bacterial AgentsDNA, Bacterialexopolysaccharide, PseudomonasExpectorantsPolysaccharides, Bacterialantibiotic susceptibilitybacterial aggregationbiofilmcystic fibrosisexopolysaccharideextracellular DNAIHCPelPseudomonas aeruginosa biofilm matrixPsl

Identifiers

PMID33626358
PMCPMC7958924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.